TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

Videos | Cath Lab | November 08, 2017
VIDEO: Cath Lab of the Future Cardiovascular Technologies to Watch

Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on...
read more
OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

OCT comparison between the Combo vs. Xience stents in the HARMONEE study.

Feature | Stents | November 08, 2017
OrbusNeich Combo Dual-therapy Stent Noninferior Vs. Xience Stent in HARMONEE Trial

November 8, 2017 – New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report...
read more
FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.
News | FFR Technologies | November 08, 2017
FAVOR II Studies Examine Accuracy of Quantitative Flow Ratio FFR-Angiography

November 8, 2017 — Investigators in the FAVOR II China and FAVOR II Europe-Japan...
read more
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology | November 08, 2017
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients

November 8, 2017 —  Medtronic plc recently presented new clinical research to support the positive clinical...
read more
Videos | Heart Valve Technology | November 08, 2017
VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis

Philippe Genereux...
read more
Videos | Heart Valve Technology | November 08, 2017
VIDEO: MAVERIC 6-month Outcomes for the Arto Mitral Valve Reshaping System

Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents...
read more
Videos | Stents Bioresorbable | November 07, 2017
VIDEO: What Went Wrong With the Absorb Stent?

A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-...
read more
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology | November 07, 2017
Harpoon Device May Improve Quality, Frequency of Mitral Repair

November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and...
read more
Videos | Heart Valve Technology | November 07, 2017
VIDEO: Update of Mitral Valve Repair and Replacement Technologies

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state...
read more
Medtronic Unveils Strong Early Outcomes for Intrepid Transcatheter Mitral Valve Replacement System
News | Heart Valve Technology | November 07, 2017
Medtronic Unveils Strong Early Outcomes for Intrepid Transcatheter Mitral Valve Replacement System

November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid...
read more
Harpoon Mitral Valve Repair System Found Safe and Effective
News | Heart Valve Technology | November 07, 2017
Harpoon Mitral Valve Repair System Found Safe and Effective

November 7, 2017 — A new study has found that a pioneering device to...
read more
HREVS study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, at TCT 2017.

Study principal investigator Vladimir Ganyukov, M.D., Ph.D., head of interventional cardiology, State Scientific Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia, explaining the HREVS trial results at TCT 2017.

News | November 06, 2017 | Dave Fornell
No Major Differences Between PCI vs. CABG vs. Hybrid Revascularization in HREVS Study

November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different...
read more
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
ORBITA Study Finds No Improvement in Exercise Time Over Placebo in PCI Patients

November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study,...
read more
Mitralign's Trialign system is used for transcatheter repair of tricuspid valve regurgitation. TCT 2017
News | Heart Valve Technology | November 06, 2017
Positive, Sustained Improvement at One Year in SCOUT I Transcatheter Tricuspid Repair Trial

November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign...
read more
Six Months of DAPT Non-Inferior to Twelve in STEMI Patients Receiving Drug-Eluting Stents. Photo courtesy of Siemens Healthineers

Photo courtesy of Siemens Healthineers

News | Antiplatelet and Anticoagulation Therapies | November 06, 2017
Six Months of DAPT Non-Inferior to Twelve in STEMI Patients Receiving Drug-Eluting Stents

November 6, 2017 —  The first trial to evaluate the safety of...
read more
© Copyright Scranton Gillette Communications. All Rights Reserved.
Overlay Init